Macro Group Pharmaceutical S.A.E. (MCRO) Financials
Annual financial statement highlights for Macro Group Pharmaceutical S.A.E. covering fiscal years 2021–2023. Figures are updated weekly.
| Fiscal year | Revenue | Net income | EPS | Free cash flow | Total assets | Total debt | Dividend per share |
|---|---|---|---|---|---|---|---|
| 2023ended Dec 2023 | 526.01M | -272.65M | -0.11 | -42.46M | 513.69M | 226.18M | — |
| 2022ended Dec 2022 | 729.61M | 173.84M | 0.07 | 132.43M | 849.63M | 204.65M | 0.02 |
| 2021ended Dec 2021 | 594.26M | 147.93M | 0.06 | 45.5M | 577.1M | 97.81M | 0.02 |
All figures in EGP, as reported in the company’s annual results; updated weekly.